On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
The coming year will be a challenging one for breast cancer physicians and researchers as new figures show that the number of breast cancer cases worldwide is on the rise.
The World Health Organisation’s International Agency for Research on Cancer (IARC) recently released the latest global statistics on cancer incidence, mortality and prevalence.
Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercise while on treatment, according to results presented at the 2013 San Antonio Breast Cancer Symposium, which is currently underway.
When a woman is diagnosed with breast cancer it is not only she who embarks on an unexpected and unwelcome journey – her partner will also inevitably experience their own challenging cancer journey.
It has been very exciting to track down Dr Elizabeth Iorns – a scientist who is conducting ground-breaking experiments in America to reduce the genetic transmission of BRCA – and realise that she grew up in New Zealand!
New research shows that a lack of clinical trials aimed specifically at younger breast cancer patients leaves knowledge gaps that could be partly to blame for their poorer survival rates.
The study, by Cancer Research UK study published in the Journal of the National Cancer Institute, analysed almost 3000 British women diagnosed with breast cancer under the age of 40.
A Missouri University of Science and Technology researcher has developed a new screening method that uses urinalysis to diagnose breast cancer – and determine its severity – before it could be detected with a mammogram.
UK scientists have discovered a number of genes which are responsible for developing resistance to a targeted medicine used in the treatment of HER2-Positive breast cancer.
The team at the Institute of Cancer Research in London examined a number of genes that were overactive in women with HER2 Positive breast cancer who had developed a resistance to the drug Lapatinib (Tykerb).
A new study shows that there’s been a small, but significant increase in the incidence of advanced breast cancer in young American women aged 25 to 39, without a corresponding increase in older women.
A recent study has found a further link between low vitamin D levels and premenopausal breast cancer.
A clinical trial comparing a shorter course of partial breast irradiation with standard whole breast irradiation has found that those who received the faster partial treatment were more likely to report side effects and poorer cosmetic outcomes.
New Zealand women were involved in the RAPID clinical trial which compared partial breast irradiation given twice daily over five to eight days with whole breast irradiation given daily over three to five weeks.